219 related articles for article (PubMed ID: 29059163)
21. IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease.
Motta RV; Culver EL
Front Immunol; 2024; 15():1272084. PubMed ID: 38433835
[TBL] [Abstract][Full Text] [Related]
22. Chromatin organization and behavior in HRAS-transformed mouse fibroblasts.
Otsuka A; Minami K; Higashi K; Kawaguchi A; Tamura S; Ide S; Hendzel MJ; Kurokawa K; Maeshima K
Chromosoma; 2024 Apr; 133(2):135-148. PubMed ID: 38400910
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments.
Abedizadeh R; Majidi F; Khorasani HR; Abedi H; Sabour D
Cancer Metastasis Rev; 2024 Jun; 43(2):729-753. PubMed ID: 38112903
[TBL] [Abstract][Full Text] [Related]
24. Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations.
Bao H; Wang W; Sun H; Chen J
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2195995. PubMed ID: 37057639
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of RAS-dependent ROS signaling extends longevity by modulating a developmental program of global gene expression.
Branicky R; Wang Y; Khaki A; Liu JL; Kramer-Drauberg M; Hekimi S
Sci Adv; 2022 Dec; 8(48):eadc9851. PubMed ID: 36449615
[TBL] [Abstract][Full Text] [Related]
26. DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis.
Smolinska A; Singer K; Golchert J; Smyczynska U; Fendler W; Sendler M; van den Brandt J; Singer S; Homuth G; Lerch MM; Moskwa P
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077614
[TBL] [Abstract][Full Text] [Related]
27. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
Jinesh GG; Brohl AS
Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218
[TBL] [Abstract][Full Text] [Related]
28. SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway.
Gong S; Xiong L; Luo Z; Yin Q; Huang M; Zhou Y; Li J
Exp Ther Med; 2022 Aug; 24(2):502. PubMed ID: 35837046
[TBL] [Abstract][Full Text] [Related]
29. Synthetic Vulnerabilities in the KRAS Pathway.
Roman M; Hwang E; Sweet-Cordero EA
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740503
[TBL] [Abstract][Full Text] [Related]
30. Nonsense-mediated RNA decay: an emerging modulator of malignancy.
Tan K; Stupack DG; Wilkinson MF
Nat Rev Cancer; 2022 Aug; 22(8):437-451. PubMed ID: 35624152
[TBL] [Abstract][Full Text] [Related]
31. A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing.
Sinha S; Barbosa K; Cheng K; Leiserson MDM; Jain P; Deshpande A; Wilson DM; Ryan BM; Luo J; Ronai ZA; Lee JS; Deshpande AJ; Ruppin E
Nat Commun; 2021 Nov; 12(1):6512. PubMed ID: 34764240
[TBL] [Abstract][Full Text] [Related]
32. Ras isoform-specific expression, chromatin accessibility, and signaling.
Nussinov R; Zhang M; Maloney R; Jang H
Biophys Rev; 2021 Aug; 13(4):489-505. PubMed ID: 34466166
[TBL] [Abstract][Full Text] [Related]
33. CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer.
Jiang L; Wang Y; Tang H; Li X; Huang C; Liu Z; Zhou F; Wang X; Li Y
Front Genet; 2021; 12():663982. PubMed ID: 34234808
[TBL] [Abstract][Full Text] [Related]
34. Poly adenosine diphosphate-ribosylation, a promising target for colorectal cancer treatment.
Jeong KY; Park M
World J Gastrointest Oncol; 2021 Jun; 13(6):574-588. PubMed ID: 34163574
[TBL] [Abstract][Full Text] [Related]
35. Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma.
Jinesh GG; Napoli M; Smallin MT; Davis A; Ackerman HD; Raulji P; Montey N; Flores ER; Brohl AS
Sci Rep; 2021 Jun; 11(1):12673. PubMed ID: 34135394
[TBL] [Abstract][Full Text] [Related]
36. 40 Years of RAS-A Historic Overview.
Fernández-Medarde A; De Las Rivas J; Santos E
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062774
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action.
Covell DG
PLoS One; 2021; 16(4):e0243336. PubMed ID: 33909629
[TBL] [Abstract][Full Text] [Related]
38. Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Ottaiano A; Scala S; Santorsola M; Trotta AM; D'Alterio C; Portella L; Clemente O; Nappi A; Zanaletti N; De Stefano A; Avallone A; Granata V; Notariello C; Luce A; Lombardi A; Picone C; Petrillo A; Perri F; Tatangelo F; Di Mauro A; Albino V; Izzo F; Rega D; Pace U; Di Marzo M; Chiodini P; De Feo G; Del Prete P; Botti G; Delrio P; Caraglia M; Nasti G
Ther Adv Med Oncol; 2021; 13():1758835921989223. PubMed ID: 33854566
[TBL] [Abstract][Full Text] [Related]
39. Targeting K-Ras and apoptosis-driven cellular transformation in cancer.
Godwin I; Anto NP; Bava SV; Babu MS; Jinesh GG
Cell Death Discov; 2021 Apr; 7(1):80. PubMed ID: 33854056
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
